89bio, Inc.
NASDAQ:ETNB
8.29 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 316.161 | 55.255 | 150.745 | 204.654 | 93.36 | 11.234 |
| Short Term Investments
| 262.709 | 132.905 | 98.288 | 106.446 | 0 | 0 |
| Cash and Short Term Investments
| 578.87 | 188.16 | 150.745 | 204.654 | 93.36 | 11.234 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 14.664 | 7.92 | 11.237 | 5.548 | 1.966 | 0.059 |
| Total Current Assets
| 593.534 | 196.08 | 161.982 | 210.202 | 95.326 | 11.316 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 2.339 | 0.455 | 0.15 | 0.166 | 0.155 | 0.033 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0.02 |
| Other Non-Current Assets
| 0.396 | 0.289 | 0.29 | 0.706 | 0.072 | 0 |
| Total Non-Current Assets
| 2.735 | 0.744 | 0.44 | 0.872 | 0.227 | 0.053 |
| Total Assets
| 596.269 | 196.824 | 162.422 | 211.074 | 95.553 | 11.369 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 8.585 | 12.502 | 6.843 | 2.065 | 0.989 | 1.509 |
| Short Term Debt
| 0.496 | 0.168 | 2.5 | 0 | 0 | 1.671 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -1.671 |
| Other Current Liabilities
| 20.53 | 11.944 | 10.194 | 6.048 | 4.62 | 2.844 |
| Total Current Liabilities
| 29.611 | 24.614 | 19.537 | 8.113 | 5.609 | 4.353 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 24.795 | 19.877 | 16.898 | 0 | 0 | 23.073 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.557 | 0.501 | 0.03 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 30.352 | 20.378 | 16.928 | 0 | 0 | 23.073 |
| Total Liabilities
| 59.963 | 44.992 | 36.465 | 8.113 | 5.609 | 27.426 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 95.553 | 24.744 |
| Common Stock
| 0.093 | 0.051 | 0.02 | 0.02 | 0.014 | 0.001 |
| Retained Earnings
| -457.432 | -315.243 | -213.217 | -123.095 | -73.596 | -16.176 |
| Accumulated Other Comprehensive Income/Loss
| 0.19 | -0.35 | -0.064 | -0.01 | -95.553 | -0.006 |
| Other Total Stockholders Equity
| 993.455 | 467.374 | 339.218 | 326.046 | 163.526 | -24.62 |
| Total Shareholders Equity
| 536.306 | 151.832 | 125.957 | 202.961 | 89.944 | -16.057 |
| Total Equity
| 536.306 | 151.832 | 125.957 | 202.961 | 89.944 | -16.057 |
| Total Liabilities & Shareholders Equity
| 596.269 | 196.824 | 162.422 | 211.074 | 95.553 | 11.369 |